NovoCure Gross Margin 2014-2024 | NVCR
Current and historical gross margin for NovoCure (NVCR) over the last 10 years. The current gross profit margin for NovoCure as of March 31, 2024 is %.
| NovoCure Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-03-31 | $0.53B | $0.39B | 74.71% |
| 2023-12-31 | $0.51B | $0.38B | 74.85% |
| 2023-09-30 | $0.50B | $0.38B | 75.55% |
| 2023-06-30 | $0.51B | $0.39B | 76.13% |
| 2023-03-31 | $0.52B | $0.41B | 77.78% |
| 2022-12-31 | $0.54B | $0.42B | 78.62% |
| 2022-09-30 | $0.54B | $0.43B | 78.64% |
| 2022-06-30 | $0.55B | $0.43B | 78.57% |
| 2022-03-31 | $0.54B | $0.42B | 78.29% |
| 2021-12-31 | $0.54B | $0.42B | 78.36% |
| 2021-09-30 | $0.55B | $0.43B | 78.98% |
| 2021-06-30 | $0.55B | $0.43B | 79.30% |
| 2021-03-31 | $0.53B | $0.42B | 79.17% |
| 2020-12-31 | $0.50B | $0.39B | 78.18% |
| 2020-09-30 | $0.45B | $0.35B | 76.67% |
| 2020-06-30 | $0.41B | $0.31B | 75.79% |
| 2020-03-31 | $0.38B | $0.29B | 75.26% |
| 2019-12-31 | $0.35B | $0.26B | 74.64% |
| 2019-09-30 | $0.32B | $0.24B | 72.98% |
| 2019-06-30 | $0.30B | $0.21B | 71.86% |
| 2019-03-31 | $0.27B | $0.19B | 69.63% |
| 2018-12-31 | $0.25B | $0.17B | 67.87% |
| 2018-09-30 | $0.23B | $0.16B | 68.67% |
| 2018-06-30 | $0.22B | $0.15B | 68.35% |
| 2018-03-31 | $0.19B | $0.13B | 68.04% |
| 2017-12-31 | $0.18B | $0.12B | 68.36% |
| 2017-09-30 | $0.15B | $0.10B | 66.67% |
| 2017-06-30 | $0.13B | $0.08B | 62.40% |
| 2017-03-31 | $0.11B | $0.06B | 52.38% |
| 2016-12-31 | $0.08B | $0.04B | 44.58% |
| 2016-09-30 | $0.07B | $0.02B | 36.92% |
| 2016-06-30 | $0.05B | $0.02B | 30.77% |
| 2015-12-31 | $0.03B | $0.01B | 38.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.063B | $0.509B |
| NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.295B | 15.60 |
| Cencora (COR) | United States | $47.007B | 18.33 |
| ICON (ICLR) | Ireland | $26.068B | 24.61 |
| DiDi Global (DIDIY) | China | $21.483B | 0.00 |
| Avantor (AVTR) | United States | $14.638B | 21.55 |
| CochLear (CHEOY) | Australia | $14.016B | 0.00 |
| Revvity (RVTY) | United States | $13.265B | 23.27 |
| Natera (NTRA) | United States | $13.164B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.413B | 40.84 |
| Viatris (VTRS) | United States | $12.216B | 3.65 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.939B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.798B | 20.67 |
| Solventum (SOLV) | United States | $9.292B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.560B | 0.00 |
| HealthEquity (HQY) | United States | $7.157B | 45.96 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.259B | 4.99 |
| Doximity (DOCS) | United States | $5.034B | 35.26 |
| PACS (PACS) | United States | $4.404B | 0.00 |
| Life Times (LTH) | United States | $3.653B | 38.27 |
| Sotera Health (SHC) | United States | $3.278B | 16.08 |
| Surgery Partners (SGRY) | United States | $3.011B | 27.55 |
| GoodRx Holdings (GDRX) | United States | $2.927B | 111.43 |
| Agilon Health (AGL) | United States | $2.612B | 0.00 |
| Progyny (PGNY) | United States | $2.413B | 41.54 |
| AMN Healthcare Services Inc (AMN) | United States | $2.019B | 8.00 |
| Premier (PINC) | United States | $1.914B | 8.19 |
| BrightSpring Health Services (BTSG) | United States | $1.785B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.637B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.356B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.176B | 0.00 | |
| CareDx (CDNA) | United States | $0.728B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| GeneDx Holdings (WGS) | United States | $0.703B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| InnovAge Holding (INNV) | United States | $0.619B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.442B | 44.05 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.432B | 0.00 |
| ModivCare (MODV) | United States | $0.370B | 6.93 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.313B | 17.11 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Sharecare (SHCR) | United States | $0.281B | 0.00 |
| MultiPlan (MPLN) | United States | $0.247B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.219B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.55 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.045B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.83 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |